aristolochic acid c has been researched along with glucose, (beta-d)-isomer in 1 studies
| Studies (aristolochic acid c) | Trials (aristolochic acid c) | Recent Studies (post-2010) (aristolochic acid c) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
|---|---|---|---|---|---|
| 10 | 0 | 5 | 21,956 | 883 | 10,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brand-Arzamendi, K; Garg, A; Liu, X; Quan, A; Shi, X; Singh, KK; Verma, S; Wen, XY; Yun, J | 1 |
1 other study(ies) available for aristolochic acid c and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial?
Topics: Animals; Animals, Genetically Modified; Aristolochic Acids; Benzhydryl Compounds; Biomarkers; Clinical Trials as Topic; Disease Models, Animal; Female; Glucosides; Heart Failure; Humans; Male; Zebrafish | 2017 |